BioCentury
ARTICLE | Clinical News

Zerbaxa ceftolozane/tazobactam regulatory update

August 3, 2015 7:00 AM UTC

EMA’s CHMP recommended approval of Zerbaxa ceftolozane/tazobactam to treat complicated intra-abdominal infections (cIAIs), acute pyelonephritis and complicated urinary tract infections (cUTIs). The co...